Literature DB >> 21514113

Outcome of midfoot amputations in diabetic gangrene.

Mohamed A Elsharawy1.   

Abstract

BACKGROUND: Persistent high incidence of limb loss resulting from advanced foot gangrene in patients with diabetes prompted an aggressive foot salvage surgery as a final attempt before below-the-knee amputation (BKA). The aim of this study was to evaluate the role of transtarsal amputations in achieving limb salvage at our vascular surgery unit, King Fahd Hospital of the University, Saudi Arabia.
METHODS: A prospective study was performed on all patients with diabetes who were admitted to the vascular surgery unit, and underwent transtarsal amputation between November 2005 and October 2010. Patients who had their forefoot removed at the tarsometatarsal level (Lisfranc amputation) or at the midtarsal joint (Chopart amputation) were included in the study. Patient factors, operative complications, operative mortality, wound healing, limb salvage, functional status, and survival rates were evaluated.
RESULTS: Over the past 4 years, 32 patients with diabetes were included in this study. Of these, 24 had Lisfranc and 8 had Chopart amputations for advanced gangrene of the foot. A total of 28 patients had evidence of arterial occlusive disease. In all, 24 patients had concomitant revascularization (bypass grafting or percutaneous transluminal angioplasty). Two patients died in the perioperative period (operative mortality: 6%). The stump did not heal in 8 patients (27%) and BKAs had to be performed. Four BKAs and 2 above-the-knee amputations were required 3-28 months later. Functional ambulation at 6 months was achieved in 20 (67%) of 30 patients.
CONCLUSION: Aggressive attempts at foot salvage are justified in patients with diabetes with advanced foot gangrene after assuring adequate arterial perfusion. Transtarsal amputations salvaged about two-thirds of the limbs studied.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21514113     DOI: 10.1016/j.avsg.2010.11.013

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  8 in total

Review 1.  The care of transmetatarsal amputation in diabetic foot gangrene.

Authors:  Michele Ammendola; Rosario Sacco; Lucia Butrico; Giuseppe Sammarco; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2016-10-03       Impact factor: 3.315

Review 2.  Autoamputation of diabetic toe with dry gangrene: a myth or a fact?

Authors:  Abdullah Al Wahbi
Journal:  Diabetes Metab Syndr Obes       Date:  2018-06-01       Impact factor: 3.168

3.  Transmetatarsal Amputation Results in Higher Frequency of Revision Surgery and Higher Ambulation Rates Than Below-Knee Amputation.

Authors:  Angel Ordaz; Conner Trimm; Jason Pedowitz; Ian M Foran
Journal:  Foot Ankle Orthop       Date:  2022-07-21

4.  Second Ray Amputation in Diabetic Foot - Functionally Better than Proximal Foot Amputations, but Beware of Charcot Arthropathy: A Case Report and Review of Literature.

Authors:  Amit Gupta; Aditya Menon; Camilla Rodrigues; Ayesha Sunavala; Vikas M Agashe
Journal:  J Orthop Case Rep       Date:  2022-03

Review 5.  Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.

Authors:  Rongqi Liu; Brian J Petersen; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

6.  Distal amputations for the diabetic foot.

Authors:  Aziz Nather; Keng Lin Wong
Journal:  Diabet Foot Ankle       Date:  2013-07-16

7.  Describe the outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review protocol for the development of shared decision-making resources.

Authors:  Michael P Dillon; Stefania Fatone; Matthew Quigley
Journal:  Syst Rev       Date:  2015-12-04

Review 8.  Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources.

Authors:  Michael P Dillon; Matthew Quigley; Stefania Fatone
Journal:  Syst Rev       Date:  2017-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.